Stoke Therapeutics, Inc. · NASDAQ:STOK
Redmile Group, LLC reported a 8.00% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Redmile Group, LLC reported a 8.00% stake in Stoke Therapeutics, Inc., 4,375,931 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 4,375,931
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 8.00% | 4,375,931 |
| Jeremy C. Green | 8.00% | 4,375,931 |
| Redmile Biopharma Investments III, L.P. | 6.40% | 3,505,612 |
Source
Related
- Stoke Therapeutics, Inc.
- Redmile Group, LLC
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · Redmile Group, LLC · May 15, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026